These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 26416212)

  • 1. Malignancy-associated pruritus.
    Rowe B; Yosipovitch G
    Eur J Pain; 2016 Jan; 20(1):19-23. PubMed ID: 26416212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved pruritus correlates with lower levels of IL-31 in CTCL patients under different therapeutic modalities.
    Cedeno-Laurent F; Singer EM; Wysocka M; Benoit BM; Vittorio CC; Kim EJ; Yosipovitch G; Rook AH
    Clin Immunol; 2015 May; 158(1):1-7. PubMed ID: 25762519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relief of intractable pruritus with romidepsin in patients with cutaneous T-cell lymphoma: A series of four cases.
    Poligone B; Rubio-Gonzalez B; Querfeld C
    Dermatol Ther; 2019 Mar; 32(2):e12804. PubMed ID: 30549384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pruritus in cutaneous T-cell lymphomas: frequent, often severe and difficult to treat.
    Meyer N; Paul C; Misery L
    Acta Derm Venereol; 2010; 90(1):12-7. PubMed ID: 20107719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of cells and mediators associated with pruritus in primary cutaneous T-cell lymphomas.
    Hu M; Scheffel J; Frischbutter S; Steinert C; Reidel U; Spindler M; Przybyłowicz K; Hawro M; Maurer M; Metz M; Hawro T
    Clin Exp Med; 2024 Jul; 24(1):171. PubMed ID: 39068637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms and treatments of neuropathic itch in a mouse model of lymphoma.
    Chen O; He Q; Han Q; Furutani K; Gu Y; Olexa M; Ji RR
    J Clin Invest; 2023 Feb; 133(4):. PubMed ID: 36520531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pruritus in cutaneous T-cell lymphoma: a review.
    Ahern K; Gilmore ES; Poligone B
    J Am Acad Dermatol; 2012 Oct; 67(4):760-8. PubMed ID: 22285672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pruritus Reduction with Systemic Anti-lymphoma Treatments in Patients with Cutaneous T Cell Lymphoma: A Narrative Review.
    Field H; Gao L; Motwani P; Wong HK
    Dermatol Ther (Heidelb); 2016 Dec; 6(4):579-595. PubMed ID: 27590615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding pruritus in systemic disease.
    Krajnik M; Zylicz Z
    J Pain Symptom Manage; 2001 Feb; 21(2):151-68. PubMed ID: 11226766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous T-cell Lymphoma and Pruritus: The Expression of IL-31 and its Receptors in the Skin.
    Nattkemper LA; Martinez-Escala ME; Gelman AB; Singer EM; Rook AH; Guitart J; Yosipovitch G
    Acta Derm Venereol; 2016 Nov; 96(7):894-898. PubMed ID: 27001482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What's New in Cutaneous T-Cell Lymphoma-Associated Pruritus.
    Biazus Soares G; Guitart J; Yosipovitch G
    Am J Clin Dermatol; 2024 Jan; 25(1):67-77. PubMed ID: 37971624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic pruritus: a paraneoplastic sign.
    Yosipovitch G
    Dermatol Ther; 2010; 23(6):590-6. PubMed ID: 21054705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraneoplastic Itch Management.
    Rowe B; Yosipovitch G
    Curr Probl Dermatol; 2016; 50():149-54. PubMed ID: 27578084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory cytokines and peripheral mediators in the pathophysiology of pruritus in cutaneous T-cell lymphoma.
    Lewis DJ; Huang S; Duvic M
    J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1652-1656. PubMed ID: 29775497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Itch: scratching more than the surface.
    Twycross R; Greaves MW; Handwerker H; Jones EA; Libretto SE; Szepietowski JC; Zylicz Z
    QJM; 2003 Jan; 96(1):7-26. PubMed ID: 12509645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does continuous subcutaneous infusion of lignocaine relieve intractable pruritus associated with advanced cutaneous T-cell lymphoma? A retrospective case series review.
    Norris J; Barker J; Buelens O; Spruijt O
    Palliat Med; 2019 May; 33(5):552-556. PubMed ID: 30712496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-22, but not IL-17, dominant environment in cutaneous T-cell lymphoma.
    Miyagaki T; Sugaya M; Suga H; Kamata M; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
    Clin Cancer Res; 2011 Dec; 17(24):7529-38. PubMed ID: 22048239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of nerve growth factor, chemokine (C-C motif) ligands and immunoglobulin E with pruritus in cutaneous T-cell lymphoma.
    Suga H; Sugaya M; Miyagaki T; Ohmatsu H; Fujita H; Kagami S; Asano Y; Tada Y; Kadono T; Sato S
    Acta Derm Venereol; 2013 Mar; 93(2):144-9. PubMed ID: 22948508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-31, a Potent Pruritus-Inducing Cytokine and Its Role in Inflammatory Disease and in the Tumor Microenvironment.
    Rook AH; Rook KA; Lewis DJ
    Adv Exp Med Biol; 2021; 1290():111-127. PubMed ID: 33559859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causes, pathophysiology, and treatment of pruritus in the mature patient.
    Shevchenko A; Valdes-Rodriguez R; Yosipovitch G
    Clin Dermatol; 2018; 36(2):140-151. PubMed ID: 29566918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.